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Abstract
Background: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder charac-
terized by abdominal pain or discomfort that is associated with altered bowel habit. Both its
prevalence and clinical characteristics vary throughout Latin America. A percentage of patients
does not seek medical attention, therefore a reliable prevalence ﬁgure can only be established
by interviewing non-selected populations.
Aims: To study the prevalence and clinical characteristics of IBS symptoms in non-selected
subjects in Santiago, Chile.
Methods: A total of 437 shopping mall visitors above the age of 15 years (246 women) partici-
pated in the study by answering the Rome II validated questionnaire for IBS. The demographic
and socioeconomic backgrounds, comorbidities, and a family history of IBS were registered.
Results: A total of 64.1% subjects reported having gastrointestinal symptoms and 28.6% had
symptoms suggestive of IBS. When the subjects with IBS symptoms were compared with the
asymptomatic individuals, a predominance of women (65.6 vs 42.9, p < 0.001) and a greater
cholecystectomy frequency (33.6 vs 12.9% p < 0.05) were observed in the former. The age of
symptom onset was 30.4 years. An equal percentage of subjects (42.4%) presented with diarrhea
and constipation and 15.2% presented with alternating IBS. Participants with a higher educa-
tional level reported a lower percentage of IBS (p < 0.05). A family history of the disease was
present in 40% of the subjects with IBS, compared with 14.9% in the asymptomatic individuals
(p < 0.05). Only 39.2% of the subjects had seen a physician for their symptoms and the treatment
and tests ordered were inappropriate.
 Please cite this article as: Madrid-Silva AM, et al. Prevalencia de síntomas de intestino irritable en población asistente a centros
comerciales de Santiago de Chile. Revista de Gastroenterología de México. 2013;78:203--210.
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Conclusions: The prevalence of IBS symptoms in the population studied is one of the highest
described. Therefore, health teams should have the necessary knowledge and skill required for
its management.
© 2013 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. All
rights reserved.
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Prevalencia de síntomas de intestino irritable en población asistente a centros
comerciales de Santiago de Chile
Resumen
Antecedentes: El síndrome de intestino irritable (SII) es un trastorno funcional digestivo carac-
terizado por dolor o malestar abdominal, asociado a alteraciones del hábito intestinal. Tanto
prevalencia como características clínicas son variables en Latinoamerica. Un porcentaje de
pacientes no consulta, la real prevalencia sólo puede establecerse encuestando población no
seleccionada.
Objetivos: Estudiar la prevalencia y características clínicas de síntomas de SII en sujetos no
seleccionados de Santiago, Chile.
Métodos: Participaron 437 mayores de 15 an˜os (246 mujeres), asistentes a centros comerciales,
quienes respondieron el cuestionario validado de Roma II para SII. Se registraron, antecedentes
demográﬁcos, socioeconómicos, comorbilidades y antecedentes familiares de SII.
Resultados: Un 64,1% relató síntomas digestivos, 28,6% síntomas sugerentes de SII. Comparando
sujetos con síntomas de SII con asintomáticos se observó en los primeros: predominio del sexo
femenino (65,6 vs. 42,9. p < 0.001) y mayor frecuencia de colecistectomía (33,6 vs. 12,9%
p < 0,05). La edad de inicio de los síntomas fue 30,4 an˜os. Se observó igual porcentaje (42,4%)
entre pacientes con diarrea y con estren˜imiento, y 15,2% alternante. Sujetos con mayor nivel
educacional reportaron menor porcentaje de SII (p < 0,05). El antecedente familiar de SII estuvo
presente en 40% de sujetos con SII, comparado con sujetos asintomáticos 14,9% (p < 0,05). Solo
39,2% consultaron al médico. El tratamiento y exámenes solicitados no estuvieron acorde con
los síntomas.
Conclusión: La prevalencia de síntomas de SII en la población estudiada es una de las más
altas descritas, por lo cual los equipos de salud debieran tener los conocimientos y destrezas
adecuados para su manejo.
© 2013 Asociación Mexicana de Gastroenterología. Publicado por Masson Doyma México S.A.
Todos los derechos reservados.
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rritable bowel syndrome (IBS) is part of a subgroup of
he so-called functional gastrointestinal disorders, cha-
acterized by abdominal pain and discomfort associated
ith changes in the bowel habit and bowel movement
isorders. The Rome criteria have established deﬁnitions
elative to both the characteristics and duration of these
lterations.1--3
Studies conducted on this group of patients have
evealed different pathophysiologic disorders such as: vis-
eral hyperalgesia,4,5 altered motility and bowel transit,2,6,7
hanges in the microbiota,8 and others associated with dis-
rders related to the psychosocial sphere.9
Its impact on the health of the population is impor-
ant, given that it constitutes a high percentage of the
astroenterologic consultations in the United States and is
signiﬁcant cause of absenteeism in the workplace.2,10 Its
conomic impact is great due to the requirements of a larger
umber of medical consultations, tests, and medicines,
ompared with the population that does not present with
BS.11--13
s
C
sThis pathology has a precocious onset and it is estimated
o affect from 10 to 15% of schoolchildren, half of whom
ontinue to present with symptoms into adulthood.14
Its prevalence is variable depending on the communities
tudied and in several Latin American countries it varies
etween 9 and 18%;15 whether these variations are real,
r are the result of studies on different population groups,
r depend on surveys using different instruments, or on
he existence or not of conﬁrmation after diagnosis, is the
ubject of debate. Today well-structured surveys are avail-
ble that make an important approach to diagnosis possible,
hile at the same time reducing the presence of organic
athology.
It is believed that the majority of patients with IBS do not
eek medical attention for their symptoms,13 and therefore
he only way to establish the true prevalence in a population
s to survey an important number of individuals from a non-
elected population. In this regard, no previous studies with
hese characteristics have been carried out.Our aim was to study the prevalence of symptoms con-
istent with IBS in a non-selected population in Santiago de
hile, using the Rome II questionnaire for IBS to conduct the
urvey.
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Have you had pain or discomfort centered in the abdomen within the 
past 12 months lasting 12 weeks?
1 
yes no
If your answer is yes, is the pain located: 
above the umbilicus and below the sternum? 
below the umbilicus?
in the entire abdomen?
What are your stools usually like?9 
Soft and formed A fluffy B watery C
A normal formed consistency D formed and hard E
like pellets F containing mucus G
containing blood H
Does your pain disappear after a bowel movement?2 
yes 
no 
When having a bowel movement do you experience any of the following
characteristics?
10 
difficulty in having the bowel movement  A pain during the bowel
urgency to defecate C
the sensation that your bowel movement was not complete D
When your abdominal pain or discomfort begins, is it associated with a
change in the number of bowel movements?
3 
yes no
Do you often have nausea or an upset stomach?11 
yes  no 
If your answer is yes, how often? 
every day A
sometimes B
with long periods between episodes C
When your abdominal pain or discomfort begins, is it associated with
the consistency of your stools?
4 
yes
yes
no
If your answer is yes:
Are they softer? A
Are they harder? B
Do you have bloating?12 
yes no
If your answer is yes, how often?
sometimes A
every day B
all day long C
after eating D
Do you often have diarrhea?5 no Do you have a heavy or full feeling after eating?yes
yes
yes
yes
yes
no
no
no
no
no
Only if your answer is yes, how often?6 
once a week A
more than twice a week B
once a month C
twice a month D
Do you vomit frequently?14 
If your answer is yes, how often?
every day A
less than 3 times a week B
less than once a month C
And in this case what are your stools like?7 
soft blobs C
containing mucus D
containing blood E
Do you have a burning sensation in the pit of your stomach?15 
What is your normal or customary bowel movement frequency?8 
every day A
more than 3 times a week B
less than 3 times a week C
Do you have a burning sensation in your chest? 16 
If your answer is yes, does acid or a small amount of liquid come up
into your mouth? 
If your answer is yes, how often? 
every day A
3 times a week B
once a week C
13
fluffy Bwatery A
movement B
Figure 1 Survey with Rome II criteria for the diagnosis of irritable bowel syndrome.
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A cross-sectional study was conducted through surveys
carried out on weekends by medical interns from the Uni-
versidad de Chile that were previously instructed in the
application of the survey.
This analysis was carried out within the time frame of
June to July of 2005 in 5 large shopping centers located
in the eastern (n = 88), central (n = 88), northern (n = 87),
western (n = 85), and southern (n = 89) areas of the city of
Santiago.
The interns applying the surveys set up at the entrances
to the shopping malls and personally invited men and women
above the age of 15 years to directly and voluntarily answer
a questionnaire, without receiving any type of compensation
or additional beneﬁt.
Epidemiologic characteristics: information on demo-
graphic characteristics were collected that included sex,
age, the area of residence in Santiago (residents of other
cities were not included), educational level, and current
occupation. The areas of residence were arranged into
5 geographic zones that resulted in general groupings of
populations of different socioeconomic levels; zone 1 rep-
resented the highest level and zone 5 the lowest level.
The educational level and occupation were grouped into
5 categories: 1) a completed university education and/or
university degree, 2) a completed high school education
a
(
t
tr incomplete university studies, 3) housewives and domes-
ic workers, 4) employed with completed technical studies,
nd 5) non-specialized workers (with partial or completed
tudies).
For the purpose of determining the prevalence of IBS
ymptoms, a Spanish language version of the Rome II mod-
lar questionnaire for functional gastrointestinal disorders
as used (Fig. 1 16).
An afﬁrmative answer to the question (Q) associated with
or more afﬁrmative answers to Q2, Q3, or Q4 and a nega-
ive answer to Q 11, Q 13, Q 14, Q 15, and Q 16 were used
s the criteria for diagnosing IBS. Diarrhea-predominant IBS
IBS-D) diagnosis: IBS criteria and 2 or more afﬁrmative
nswers to Q 4A, Q 5, Q 6B, Q 7A-D, Q 9-C, and Q 10C.
Constipation-predominant IBS (IBS-C) diagnosis: IBS crite-
ia and 2 or more afﬁrmative answers to Q 4B, Q 8C, Q 9 D-F,
10 A-D.
For the diagnosis of alternating IBS (IBS-A), the criteria
or IBS and an afﬁrmative answer to Q 4A and B and Q 9A
nd F were used.
The questions referred to the presence of comorbidity
high blood pressure, diabetes mellitus, chronic liver dam-
ge, nephropathy), past surgical history, use of medication
t the time of the survey, a family history of IBS diagnosis
parents, brothers or sisters, grandparents, aunts or uncles),
ests done because of symptoms, and age at onset of gas-
rointestinal symptoms.
2 A.M. Madrid-Silva et al.
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Figure 2 Distribution percentage of men and women with
irritable bowel symptoms in different age groups. Signiﬁcant
differences can be seen when comparing men and women in
the 46-60 year age group with those under 30 years of age and
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ample size
ecause there were no previous studies reporting IBS preva-
ence in Chile, the estimate presented at the Latin American
onsensus on Irritable Bowel Syndrome, corresponding to a
aximum prevalence of 18%, was used to calculate sample
ize.15 According to the formula used for this calculation, we
stablished a minimum sample size of 391 surveys to reach
0% power and an alpha level of 0.05.
tatistical analysis
ll the eligible surveys were given a correlated code num-
er, keeping the identity of the subjects conﬁdential. The
TATA 9.0 software was used for the data analysis. Age and
BS presence (with and without the variable of sex) were
ompared using the Student’s t test. The Pearson chi-square
est or the Fisher exact test were used to compare the cat-
gorical variables. Possible risk factors, such as female sex,
family history of IBS, and occupational level were deter-
ined through the logistic regression analysis. Odds ratio
as calculated with a 95% conﬁdence interval.
Data were presented as mean ± standard deviation. All
he calculations were two-tailed p values and statistical sig-
iﬁcance was considered with a p < 0.05.
thics committee
his study was approved by the Scientiﬁc Ethics Committee
f the Hospital Clínico Universidad de Chile.
esults
total of 437 surveys were taken, corresponding to 191
en and 246 women, with a mean age of 42.8± 14.9 and
2.9± 14.4 years, respectively, and a range of 15-82 years.
ne hundred ﬁfty-four subjects (35.2%) stated they had no
astrointestinal symptoms during the time period managed
n the survey (Table 1).
Two hundred eighty-three subjects (64.8%) said they
ad gastrointestinal symptoms. One hundred twenty-ﬁve
ubjects (28.6%) reported symptoms consistent with IBS
ccording to the Rome II criteria. Fifty-three subjects
42.4%) were observed in both the IBS-D and the IBS-C sub-
roups, and only 19 (15.2%) presented with IBS-A. There
ere no differences in relation to sex.
The remaining subjects corresponded to a group of
atients with heterogeneous symptoms, among which
eﬂux, epigastric pain, and dyspepsia were predominant.
ther existing symptoms were not tabulated.
emographic background
pon comparing the demographic data of the subjects with
BS symptoms and the asymptomatic ones, a greater pro-
ortion of women was observed in the IBS group (65.6%),
hereas the percentage of women was 42.9% in the asymp-
omatic subjects. On the other hand, there were no
ifferences in the ages of the patients in the two groups
45.2 years vs-. 41.1 years).
w
s
obove 60 years of age.
p < 0.05.
The sex distribution percentage of the different patient
ges in the IBS group is shown in Figure 2: the percentage of
omen patients with IBS symptoms progressively increased
ith age, reaching a maximum 46-60 years; there were sig-
iﬁcant differences with men from the same age group and
ith older or younger women (p < 0.05). In contrast, there
ere no age-related variations in men.
Regarding the educational level (Table 1), the majority
f the surveyed subjects, whether presenting IBS symp-
oms or asymptomatic, were in level 4 (technical studies).
hen comparing the percentage distribution of the subjects
ith IBS symptoms and the asymptomatic ones, a lower IBS
ercentage was seen in the group with a higher level of edu-
ation; there were no differences in the other groups. In
elation to the area of residence, the majority of the sub-
ects lived in areas 1 and 5; there were no differences in
he distribution percentage between the subjects with and
ithout IBS symptoms in the different areas of residence
Table 1).
isk factors for irritable bowel syndrome
family history of IBS was present in 40% of the IBS subjects,
hereas only 14.9% of the asymptomatic subjects stated
aving such a history (p < 0.001) (Table 1).
The univariate analysis of the evaluated factors showed
hat women had a greater risk for IBS, but it was not statis-
ically signiﬁcant (p = 0.057). The presence of family history
as signiﬁcant (p < 0.01). Having a university education was
ssociated with a lower presence of IBS symptoms and was
tatistically signiﬁcant (p < 0.02).
A past history of surgery was found in 107 subjects and
he number of surgeries was 108 (38.7%). The most fre-
uent procedures were cholecystectomy, appendectomy,
nd gynecologic interventions. Table 2 shows that more
han twice the number of subjects with IBS underwent
holecystectomy compared with the asymptomatic subjects
p < 0.05). This difference was maintained when only women
ere taken into account. In contrast, appendectomy pre-
ented with a similar frequency in both groups.
A very low proportion of other surgical procedures was
bserved in the two groups.
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Table 1 Epidemiologic background of the surveyed subjects.
Total Asymptomatic IBS Other
symptoms
p
No. (%) 437 100 154 35.2 125 28.6 158 36.15 NS
Years: mean± SD 42.7± 14.6 41.1± 15.5 45.2± 15.2 42.5± 13.0 NS
Age range 15-82 15-71 17-82 18-81 NS
Sex M/W
(%)
191/246 43.7 56.3 88/66
57.1 42.9
43/82
34.4 65.6a
60/98
38 62.0b
0.001a
0.001b
No. (%) No. (%) No. (%) No. (%) p
Area of residence
1 122 (100) 60 (49.2) 35 (28.6) 27 (22.1) NS
2 48 (100) 12 (25.0) 9 (18.7) 27 (56.3) NS
2 53 (100) 10 (18.9) 14 (26.4) 29 (54.7) NS
4 87 (100) 34 (39.0) 23 (26.5) 30 (34.5) NS
5 127 (100) 38 (30.0) 44 (34.6) 45 (35.4) NS
Educational level
1 98 (100) 47 (48.0) 15 (15.3)c 36 (36.3) <0.01c
2 58 (100) 26 (44.1) 19 (32.2) 14 (23.7) NS
3 78 (100) 19 (24.4) 26 (33.3) 33 (42.3) NS
4 174 (100) 54 (31.0) 54 (31.0) 66 (38.0) NS
5 28 (100) 8 (28.6) 11 (39.3) 9 (32.1) NS
Family history of IBS 121 (27.6) 23 (14.9) 50 (40)d 48 (30.3) <0.001d
a upon comparing the group presenting with IBS symptoms and the asymptomatic group.
b upon comparing the group presenting with other gastrointestinal symptoms and the asymptomatic group.
c upon comparing the group 1 subjects presenting with IBS symptoms and the other groups.
d upon comparing the group presenting with IBS symptoms and the asymptomatic group.
Table 2 Clinical data of the subjects with symptoms of irritable bowel syndrome and the asymptomatic subjects.
Irritable bowel syndrome Asymptomatic
Surgeries
Cholecystectomy 42 (33. 6%)* 20 (12.9%)
Appendectomy 13 (10.4%) 19 (12.3%)
Gynecologic surgery 7 (5.6%) 0
Others 4 (3.2%) 3 (1.9%)
Total 66 (52.8%)* 42 (27.2%)
Concomitant Pathologies
High Blood Pressure 28 (22.4%)* 19 (1.3%)
Diabetes Mellitus 14 (11.2%)* 6 (3.8%)
Others 20 (16%)* 9 (5.8%)
Total 62 (49.6%)* 34 (22.07%)
tom
t
t
q
t
D* p < 0.05 upon comparing the subjects presenting with IBS symp
In the concomitant pathology analysis (Table 2), high
blood pressure and diabetes mellitus stood out and their
frequency was signiﬁcantly greater in the patients with IBS
symptoms (p < 0.05).
The mean age for IBS symptom onset was 30.4 years, with
a range of 11 to 69 years.
Forty-nine (39.2%) of the subjects with IBS had seen
a physician. Of those subjects, tests were ordered for 28
of them; the most frequent was endoscopy, performed in
13 of the subjects, blood tests in 8, abdominal ultrasound
in 4, and abdominal ultrasound plus endoscopy in 3 sub-
jects.
O
s
d
ps and the asymptomatic subjects.
Of the 49 subjects with IBS that had a medical consul-
ation, 37 (75.5%) reported having received some kind of
reatment for their symptoms (Table 3) and the most fre-
uently used drug was a proton pump inhibitor in 35.1% of
he cases.
iscussionur results showed a high frequency of gastrointestinal
ymptoms in a population visiting large shopping malls in
ifferent areas of Santiago (64.8%). Of those subjects, 28%
resented with symptoms that were consistent with IBS
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Table 3 Drug use in the patients with IBS symptoms.
Drugs Irritable bowel syndrome
PPI 13 (35.1%)
Antispasmodics 12 (29.7%)
Prokinetics 1 (2.7%)
Others 12 (32.4%)
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PPI: Proton pump inhibitors.
ccording to the Rome II criteria. The remaining clinical
anifestations could not be adequately evaluated due to
he fact that the survey only included questions from the
ome II criteria for deﬁning IBS.
eneral characteristics
n Latin America, a prevalence of IBS between 9 and 18% has
een described,15 which is similar to that reported for the
ispanic population in the United States.17
In Europe, a telephone survey encompassing a large num-
er of participants, revealed an overall prevalence of 11.5%;
t was higher in Italy and in the United Kingdom.18 A sur-
ey of 5,000 patients in the United States reported a 14.1%
revalence.19 Two recent studies in Mexico showed an IBS
revalence of close to 16%,20,21 in Colombia a somewhat
igher ﬁgure of 19.9% was reported,22 and in Uruguay this
revalence was 10.9%.23
In Chile, a survey was applied to Chilean gastroenterolo-
ists in which they were asked if they thought they presented
ith IBS. There was an afﬁrmative response in 22% of those
urveyed.24
From the data obtained in the present study, we can say
hat the population visiting shopping malls in different areas
f Santiago has a high prevalence of IBS symptoms at 28.6%,
ne of the highest in the world, similar to that observed in
igeria.25
It is difﬁcult to establish the factors that could be related
o this greater IBS prevalence in Chile. Unlike other patholo-
ies, such as cholelithiasis, the ethnic factor does not
eem to be relevant, given that a recent communication26
eported a prevalence of 22% in a rural mapuche population,
nly slightly lower than the ﬁgure observed in the present
tudy. Taking into account that there are no previous stud-
es that would enable variability over periods of time to be
stablished in relation to IBS prevalence, it can only be spec-
lated that the very relevant socioeconomic changes have
een the main variant in the last decades in the Chilean
nvironment.
Age at the time of onset is within the ranges that have
een established in other studies, even though this variable
s not clearly deﬁned in the main studies.27--29 A mean of 42
ears has been estimated in Latin America.15
Regarding the IBS-D and IBS-C subgroups, the low preva-
ence in our study of the alternating group in which both
ymptoms are present is striking, compared with that
bserved in a European study in which this presentation
orm was observed in 63% of the cases.18 Nevertheless, the
esults observed in different reviews indicate much variabil-
ty in this respect in the different populations studied, a fact
t
I
o
pA.M. Madrid-Silva et al.
hat is partially dependent on the methodology employed for
stablishing the diagnosis.18,27,28
isk factors
s reported in other studies, a higher prevalence of IBS
ymptoms was associated with women30 and with the age
roup of 46-60 years in the present study; statistical sig-
iﬁcance was not reached in relation to the total group
articipating in the survey.
It was interesting that the group with the highest educa-
ional level presented with a signiﬁcantly lower percentage
f IBS symptoms; there are no articles in the literature
hat directly analyze this factor. One study suggests that a
ower socioeconomic level and a higher level of anxiety are
ssociated with a greater IBS prevalence.31 However, the
ocioeconomic factor did not seem to have a direct relation
n our study, given that the distribution in relation to areas
f residence that could have very different populations, was
imilar in this aspect. It is possible that the educational
evel per se could be conducive to a better adaptation to
he symptoms.
A total of 40% of the subjects with IBS symptoms had a
amily history of the same pathology, compared with 14.9%
f the asymptomatic subjects. This was an important distinc-
ive factor between the two groups, and similar observations
ave been made in other studies.32,33
The interpretation of these data is complex. Some studies
trongly suggest a familial inﬂuence; children whose parents
resent with IBS have been shown to have a higher number
f medical consultations.34 Evidence supporting a genetic
actor is based on studies that show a greater concordance
n monozygotic twins, compared with dizygotic twins,35,36
ut this ﬁnding has not been conﬁrmed in all the studies.37
Different investigations have associated IBS with the
olymorphism of the serotonin transporter, IL-10, the chole-
ystokinin receptor, and others.37,38
edical impact
hen analyzing the characteristics of the group of patients
ith IBS, it should be taken into account that a percentage
f them probably are organic pathology carriers, especially
hose of the IBS-D group. Their evaluation could lead to
stablishing other diagnoses such as: microscopic colitis,
eliac disease, and inﬂammatory bowel disease. The per-
entage of organic pathology with these characteristics that
ould be present in this group of patients was not analyzed
n the present study.
Some studies have reported a greater number of sur-
eries in IBS patients,27,39 especially cholecystectomy, but
lso appendectomy and gynecologic surgery, and this phe-
omenon was also observed in our survey.
It is interesting that 33.6% of the subjects with IBS
ad undergone cholecystectomy, compared with 13% of the
symptomatic subjects. This proportion was maintained only
n the analysis of the female patients. It is possible that
he presence of gastrointestinal symptoms in patients with
BS is a determining factor in a more frequent diagnosis
f cholelithiasis that results in cholecystectomy, even as a
rophylactic measure. This is a widely accepted criterion
of s
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in the Chilean medical environment. The association with
organic pathologies such as high blood pressure that do not
compromise the gastrointestinal tract is not clear.
The percentage of patients that visited a physician was
similar to that described in another study.28 It is conspicuous
that the majority of the tests done (upper gastrointesti-
nal endoscopy) and the therapy administered (proton pump
inhibitors) had little relation to the symptoms the patients
most likely described to their attending physicians; this
can have an important economic impact on local health
organizations.40
It is possible that, depending on the respective spe-
ciality of the attending physician, fewer diagnostic criteria
of functional gastrointestinal disorders, in accordance with
the symptoms reported by the patient, are employed. As
a result, a greater difference between the question asked
by the attending physician and the interpretation of the
patient’s response would be observed.
In conclusion, according to the results of our survey, the
group being studied presented with one of the highest fre-
quencies of IBS-type symptoms. Even if only some of these
patients seek medical attention for their symptoms, the
required information and orientation in relation to their ade-
quate management should be reﬂected in the undergraduate
study programs in general medicine and in the postgraduate
courses for specialists.
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